This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second Look: Digging into the phase 3 clinical trial data on CAPLYTA in patients with MDD which was presented at ACNP 2025
Ticker(s): ITCI, JNJWho's the expert?
Institution: Iowa Psychiatry
- Board certified adult Psychiatrist with Iowa Psychiatry.
- Currently manages 600 patients for major depressive disorder.
Interview Goalto discuss the current treatment landscape and the potential of CAPLYTA, as and adjunctive therapy for the treatment of MDD.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
